BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 17852834)

  • 1. Elevated fecal and serum calprotectin in COVID-19 are not consistent with gastrointestinal symptoms.
    Shokri-Afra H; Alikhani A; Moradipoodeh B; Noorbakhsh F; Fakheri H; Moradi-Sardareh H
    Sci Rep; 2021 Nov; 11(1):22001. PubMed ID: 34753964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic value of fecal calprotectin in primary care patients with gastrointestinal symptoms: A retrospective Swedish cohort study.
    Rendek Z; Falk M; Grodzinsky E; Kechagias S; Hjortswang H
    JGH Open; 2023 Oct; 7(10):708-716. PubMed ID: 37908296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of Inflammation in the Pathogenesis of Diverticular Disease.
    Tursi A; Elisei W
    Mediators Inflamm; 2019; 2019():8328490. PubMed ID: 31001067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Faecal Calprotectin.
    Pathirana WGW; Chubb SP; Gillett MJ; Vasikaran SD
    Clin Biochem Rev; 2018 Aug; 39(3):77-90. PubMed ID: 30828114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid Fecal Calprotectin Test and Symptom Index in Monitoring the Disease Activity in Colonic Inflammatory Bowel Disease.
    Puolanne AM; Kolho KL; Alfthan H; Ristimäki A; Mustonen H; Färkkilä M
    Dig Dis Sci; 2017 Nov; 62(11):3123-3130. PubMed ID: 28948412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of Laboratory Tests in Crohn's Disease.
    Cappello M; Morreale GC
    Clin Med Insights Gastroenterol; 2016; 9():51-62. PubMed ID: 27656094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble ST2 is a sensitive clinical marker of ulcerative colitis evolution.
    Díaz-Jiménez D; De la Fuente M; Dubois-Camacho K; Landskron G; Fuentes J; Pérez T; González MJ; Simian D; Hermoso MA; Quera R
    BMC Gastroenterol; 2016 Aug; 16(1):103. PubMed ID: 27565556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fecal calprotectin: a marker for clinical differentiation of microscopic colitis and irritable bowel syndrome.
    von Arnim U; Wex T; Ganzert C; Schulz C; Malfertheiner P
    Clin Exp Gastroenterol; 2016; 9():97-103. PubMed ID: 27147826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fecal calprotectin: its scope and utility in the management of inflammatory bowel disease.
    Ikhtaire S; Shajib MS; Reinisch W; Khan WI
    J Gastroenterol; 2016 May; 51(5):434-46. PubMed ID: 26897740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Semiquantitative fecal calprotectin test in postinfectious and non-postinfectious irritable bowel syndrome: cross-sectional study.
    David LE; Surdea-Blaga T; Dumitrascu DL
    Sao Paulo Med J; 2015; 133(4):343-9. PubMed ID: 26039537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomarkers as potential treatment targets in inflammatory bowel disease: A systematic review.
    Murdoch T; O'Donnell S; Silverberg MS; Panaccione R
    Can J Gastroenterol Hepatol; 2015 May; 29(4):203-8. PubMed ID: 25965441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accuracy of Rapid Fecal Calprotectin Test in Monitoring Inflammatory Bowel Diseases Under Treatment with TNFα Antagonists.
    Tursi A; Elisei W; Picchio M; Giorgetti G; Brandimarte G
    Dig Dis Sci; 2015 May; 60(5):1406-13. PubMed ID: 25445163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of six different calprotectin assays for the assessment of inflammatory bowel disease.
    Labaere D; Smismans A; Van Olmen A; Christiaens P; D'Haens G; Moons V; Cuyle PJ; Frans J; Bossuyt P
    United European Gastroenterol J; 2014 Feb; 2(1):30-7. PubMed ID: 24918006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased faecal calprotectin predicts recurrence of colonic diverticulitis.
    Tursi A; Elisei W; Picchio M; Brandimarte G
    Int J Colorectal Dis; 2014 Aug; 29(8):931-5. PubMed ID: 24798630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Faecal calprotectin in colonic diverticular disease: a case-control study.
    Tursi A; Brandimarte G; Elisei W; Giorgetti GM; Inchingolo CD; Aiello F
    Int J Colorectal Dis; 2009 Jan; 24(1):49-55. PubMed ID: 18941760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fecal calprotectin: assessment of a rapid test.
    Vestergaard TA; Nielsen SL; Dahlerup JF; Hornung N
    Scand J Clin Lab Invest; 2008; 68(4):343-7. PubMed ID: 17852834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new fecal calprotectin test for colorectal neoplasia. Clinical results and comparison with previous method.
    Johne B; Kronborg O; Tøn HI; Kristinsson J; Fuglerud P
    Scand J Gastroenterol; 2001 Mar; 36(3):291-6. PubMed ID: 11305517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new rapid home test for faecal calprotectin in ulcerative colitis.
    Elkjaer M; Burisch J; Voxen Hansen V; Deibjerg Kristensen B; Slott Jensen JK; Munkholm P
    Aliment Pharmacol Ther; 2010 Jan; 31(2):323-30. PubMed ID: 19817723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Calprotectin levels in patients with idiopathic inflammatory bowel disease comparison of two commercial tests].
    Malícková K; Janatková I; Bortlík M; Komárek V; Lukás M
    Epidemiol Mikrobiol Imunol; 2008 Nov; 57(4):147-53. PubMed ID: 19069028
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.